Identity
- Trade Name
- BinaxNOW® G6PD FDA UDI
- Generic Name
- Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, kit, rapid ICT, clinical FDA UDI
- Device Name
- For the qualitative detection of G6PD enzyme activity in blood. FDA UDI
- Model / Reference
- 780-000 FDA UDI
- Description
- For the qualitative detection of G6PD enzyme activity in blood. FDA UDI
Identifiers
- Primary DI / UDI-DI
- 10811877010705 FDA UDI
- FDA Product Code
- JBF FDA UDI
- GMDN Term
- Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, kit, rapid ICT, clinical FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 864.7360 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
Yes
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, kit, rapid ICT, clinical
BinaxNOW® G6PD by Alere Scarborough, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Alere Scarborough, Inc.
Sources (1)
- FDA UDI 43782341-ea3c-45e5-a6ee-24ac7ec86662 33 fields · synced Jun 1, 2026